Geron (GERN) Cash from Operations (2010 - 2026)
Geron (GERN) posted Cash from Operations of 62906000.0 for Q1 2026, down 185.07% sequentially from 22067000.0 in Q4 2025, and down 31.11% YoY from 91315713.84 in Q1 2025.
Geron (GERN) Cash from Operations (2010 - 2026) Analysis & Trends
Geron has reported Cash from Operations for 17 years, with the latest figure at 62906000.0 in Q1 2026.
- Quarterly Cash from Operations fell 31.11% year-over-year to 62906000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 125964000.0 (up 38.36% YoY) and the FY2025 annual result came in at 111037000.0, up 49.21% from the prior year.
- Cash from Operations eased to 62906000.0 in Q1 2026 per GERN's latest filing, from 22067000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 13576000.0 in Q3 2025 and troughed at 62906000.0 in Q1 2026.
- A 5-year average of 40451941.18 and a median of 40938000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations plunged 80.66% in 2024, then surged 76.97% in 2025.
- Over 5 years, Cash from Operations stood at 35181000.0 in 2022, then slipped by 16.36% to 40938000.0 in 2023, then decreased by 7.35% to 43945000.0 in 2024, then soared by 49.78% to 22067000.0 in 2025, then tumbled by 185.07% to 62906000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 62906000.0, 22067000.0, and 13576000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - | -15.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.83 Mn |
| Jun 30, 2026 | -15.83 Mn |
| Mar 31, 2026 | -62.91 Mn |
| Mar 31, 2026 | -62.91 Mn |
| Dec 31, 2025 | -22.07 Mn |
| Dec 31, 2025 | -22.07 Mn |
| Sep 30, 2025 | -13.58 Mn |
| Sep 30, 2025 | -13.58 Mn |
| Jun 30, 2025 | -27.42 Mn |
| Jun 30, 2025 | -27.42 Mn |
| Mar 31, 2025 | -47.98 Mn |
| Mar 31, 2025 | -47.98 Mn |
| Dec 31, 2024 | -43.95 Mn |
| Dec 31, 2024 | -43.95 Mn |
| Sep 30, 2024 | -58.94 Mn |
| Sep 30, 2024 | -58.94 Mn |
| Jun 30, 2024 | -53.48 Mn |
| Jun 30, 2024 | -53.48 Mn |
| Mar 31, 2024 | -62.25 Mn |
| Mar 31, 2024 | -62.25 Mn |